Related references
Note: Only part of the references are listed.[18F]mFBG PET/CT imaging outperforms MRI and [68 Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma
Diederik P. D. Suurd et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study
Atia Samim et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients
Elin Pauwels et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
18F-MFBG PET/CT Is an Effective Alternative of 68Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma
Peipei Wang et al.
CLINICAL NUCLEAR MEDICINE (2023)
Similar Findings on 18F-MFBG PET/CT and 68Ga-DOTATATE PET/CT in a Patient With Widespread Metastatic Pheochromocytoma
Peipei Wang et al.
CLINICAL NUCLEAR MEDICINE (2022)
Comparison of 18F-MFBG and 68Ga-DOTATATE PET/CT in the Imaging of Metastatic Paraganglioma and Pheochromocytoma
Maoxue Deng et al.
CLINICAL NUCLEAR MEDICINE (2022)
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour
Elin Pauwels et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma
Mariam S. Aboian et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments
Atia Samim et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S. Irwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma
M. L. Tas et al.
EUROPEAN JOURNAL OF CANCER (2020)
18F-meta-fluorobenzylguanidine (18F-mFBG) to monitor changes in norepinephrine transporter expression in response to therapeutic intervention in neuroblastoma models
Stephen Turnock et al.
SCIENTIFIC REPORTS (2020)
Roles of PET/Computed Tomography in the Evaluation of Neuroblastoma
Zhe Wen et al.
PET CLINICS (2020)
Increased Gastric MIBG Activity as a Normal Variant
Xia Bai et al.
CLINICAL NUCLEAR MEDICINE (2019)
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma
Bin Liu et al.
CLINICAL NUCLEAR MEDICINE (2018)
Guidelines on nuclear medicine imaging in neuroblastoma
Zvi Bar-Sever et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting
Julie R. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Norepinephrine Transporter as a Target for Imaging and Therapy
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015
Frank Berthold et al.
PEDIATRIC DRUGS (2017)
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
Kristopher R. Bosse et al.
CANCER (2016)
Focally Increased MIBG Activity in the Muscle Real Lesion or LOVENOX Injection Artifact?
Xia Bai et al.
CLINICAL NUCLEAR MEDICINE (2016)
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database
Daniel A. Morgenstern et al.
EUROPEAN JOURNAL OF CANCER (2016)
Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors
Seigo Kinuya et al.
ANNALS OF NUCLEAR MEDICINE (2015)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R. Pinto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
Shih-ying Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Imaging the Norepinephrine Transporter in Neuroblastoma: A Comparison of [18F]-MFBG and 123I-MIBG
Hanwen Zhang et al.
CLINICAL CANCER RESEARCH (2014)
Persistent Intense MIBG Activity in the Liver Caused by Prior Radiation
Jigang Yang et al.
CLINICAL NUCLEAR MEDICINE (2014)
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter
Hanwen Zhang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
Gregory A. Yanik et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Comparison of 123I-Metaiodobenzylguanidine (MIBG) and 131I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Children's Oncology Group
Arlene Naranjo et al.
PEDIATRIC BLOOD & CANCER (2011)
False-Positive MIBG Uptake in Pneumonia in a Patient With Stage IV Neuroblastoma
Tim Schindler et al.
CLINICAL NUCLEAR MEDICINE (2010)
131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET
Chang-Lae Lee et al.
MEDICAL PHYSICS (2010)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
